News | SummitMD
News
News | SummitMD
POST-PCI raises red flags for routine functional testing in high-risk PCI patients
2-year follow-up of PCI patients at high anatomical, clinical risk showed no survival benefits with surveillance testing over standard care
News | AP VALVES & SH 2022
SAVR always better for younger AS? 'Durability data up to 10-years greenlights TAVR for patients between 65-70'
Long-term valve durability becomes crucial for younger AS populations; intermediate-term data strengthens case for TAVR in select patients under 70 years
News | AP VALVES & SH 2022
Data on TAVR-related stroke 'not enough, hard to justify routine EPD use except in BAV, ViVs,'
David J. Cohen, MD says field 'just not that good' at predicting TAVR-related stroke and its effects, but EPDs help patients with bicuspid valves, ViV procedures for now
News | AP VALVES & SH 2022
Not just alternative to SAVR: 'TAVR has become standard of treatment for severe, symptomatic AS'
AMC Heart Institute's Chairman Seung-jung Park, MD, PhD says 'For Tissue Valves, SAVR is Alternative to TAVR' in Severe, Symptomatic AS Patients Over 65 Years
News | AP VALVES & SH 2022
Promising new TAVR techniques, valves to realize ideal of '1 procedure, 1 valve' for life
Eberhard Grube, MD Addresses THV Newcomers, Caveats in Evolving Field of TAVR at AP VALVES & SH 2022
News | SummitMD